1 min read
On-Demand Webinar: Natural History Study for Ultra-Rare Diseases
Were you able to join Veristat’s live webinar- “Strategies for Solving the Challenges of an Extraordinary Natural History Study – Navigating the Patient Experience When Pivoting to a Virtual Model Mid-Study”?
![FierceBio Webinar post play button](https://www.veristat.com/hs-fs/hubfs/FierceBio%20Webinar%20post%20play%20button.jpg?width=332&name=FierceBio%20Webinar%20post%20play%20button.jpg)
Learning points:
- The need for and challenges of a Natural History study of Canavan Disease
- Case Study: Strategies for addressing challenges of a unique study design
- Pivoting to a virtual & in-person hybrid model during COVID-19
Click here to watch a replay of this webinar.
Meet the Veristat team:
Rachel Smith
Portfolio Director, Veristat
Rachel has worked in clinical research for over 10 years working across all clinical phases (I-IV) with a focus on complex advanced therapy trials. She’s worked closely with innovative biopharma across different therapeutic areas. Rachel is currently the Portfolio Director of global cell and gene therapy programs, and the lead for the Veristat Global Cell and Gene Center of Excellence. She has a BSc (Hons) Biochemistry from the University of Warwick, is a Registered Member of the Institute of Clinical Research and has been published in the European Journal of Drug Metabolism and Pharmacokinetics and Lambert Academic publishing.
Kara Langer
Senior Project Manager, Veristat
Kara is a clinical operations professional with 13 years’ experience, specializing in rare disease, gene therapy, COVID-19, and Oncology. Prior to Veristat, Kara held several roles at Covance before becoming a Project Manager. Kara is currently a Senior Project Manager at Veristat, dedicated to promoting subject safety, generating high-quality data, and maximizing study efficiency. She has a Bachelor of Science from the University of Wisconsin-Madison in Natural Sciences-Genetics and Anthropology.
Get the Latest News
Categories
- Regulatory Consulting (91)
- Regulatory Submissions (86)
- Clinical Trial Regulations (67)
- COVID-19 (46)
- Strategic Consulting (26)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (14)
- Success Stories (13)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- Medical Writing (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Oncology (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
2 min read
Triangle Perspective on AI, ML, & the Future of Drug Development
Jun 7, 2024 Veristat Events
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...
2 min read
2024 ASCO Annual Meeting
May 3, 2024 Veristat Events
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
The Science-First CRO™ and Consultancy Ready to...